Skip to main content
Clinical Trials/NCT06654635
NCT06654635
Recruiting
Not Applicable

Comparison Between Ultrasound Guided Rhomboid Intercostal Plane Block and Thoracic Erector Spinae Plane Block in Patients Undergoing Upper Abdominal Surgery: A Randomized Controlled Trial

Tanta University1 site in 1 country60 target enrollmentJanuary 1, 2024

Overview

Phase
Not Applicable
Intervention
Rhomboid intercostal plane block
Conditions
Ultrasound
Sponsor
Tanta University
Enrollment
60
Locations
1
Primary Endpoint
Total morphine consumption
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

The aim of the work is to evaluate the analgesic efficacy of ultrasound guided rhomboid intercostal plane block versus ultrasound guided thoracic erector spinae block in patients undergoing upper abdominal surgery.

Detailed Description

Abdominal surgery is one of the most definitive and mainstay treatment options for abdominal pathologies in clinical practice. Acute postoperative pain is a major challenge in the postoperative period. The improved safety and efficacy that ultrasound brings to regional anesthesia helped promote its use and realize the benefits that regional anesthesia has over general anesthesia, such as decreased morbidity and mortality, superior postoperative analgesia, cost-effectiveness, decrease postoperative complications and an improved postoperative course .

Registry
clinicaltrials.gov
Start Date
January 1, 2024
End Date
May 1, 2025
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Omima Mohammed Fakher Eldin Ali

Assistant Lecturer of Anesthesiology, Surgical Intensive Care and Pain Medicine, Faculty of Medicine, Tanta University, Tanta, Egypt.

Tanta University

Eligibility Criteria

Inclusion Criteria

  • Patients aged 21-65 years.
  • Both gender.
  • American Society of Anesthesiologists (ASA) classification I-II.
  • Presented for elective upper abdominal surgery.

Exclusion Criteria

  • Patients refused to participate.
  • Patients with known or suspected allergy to the used medication.
  • Patients with preoperative chronic pain.
  • Patients with major cardiac, renal, respiratory, or hepatic disease.
  • Patients with potential risk of coagulopathy.
  • Obese patients with body mass index (BMI) \>35.

Arms & Interventions

Rhomboid intercostal plane block group

The patients in this group will receive ultrasound -guided rhomboid intercostal plane block after induction of general anesthesia. The rhomboid intercostal block will be performed at the T6 levels, bilaterally.

Intervention: Rhomboid intercostal plane block

Erector spinae plane block group

The patients in this group will receive ultrasound -guided Erector spinae plane block after induction of general anesthesia. ESP block will be performed at the level of T9 bilaterally.

Intervention: Erector spinae plane block

Control group

No block will be performed, and patient will receive general anesthesia (GA) only.

Intervention: Control group

Outcomes

Primary Outcomes

Total morphine consumption

Time Frame: 24 hours postoperatively

Rescue analgesia will be provided in the form of IV morphine 3 mg boluses if the patient indicates The visual analogue scale (VAS). ≥ 4 with maximum dose 20 mg for 24 hours. The total amount of morphine (mg) given will be recorded for the 3 groups.

Secondary Outcomes

  • Degree of pain(24 hours postoperatively)
  • Time to 1st request of rescue analgesia(24 hours postoperatively)
  • Heart rate(Every 15 min till the end of surgery)
  • Mean arterial blood pressure(Every 15 min till the end of surgery)
  • Incidence of side effects(24 hours Postoperatively)

Study Sites (1)

Loading locations...

Similar Trials